SCHEMBL4594796

SCHEMBL4594796

O=C1CCc2cc(B(O)O)ccc2N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.50
MAPK13 O15264 1/20 0.50
MAPK12 P53778 1/20 0.50
MAPK11 Q15759 1/20 0.50
MAPK14 Q16539 1/20 0.50
KIF11 P52732 2/20 0.49
PDE3B Q13370 3/20 0.46
PDE3A Q14432 3/20 0.46
TBXAS1 P24557 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP11B1 P15538 2/20 0.46
CYP11B2 P19099 2/20 0.46
CYP2C9 P11712 1/20 0.46
CRBN Q96SW2 3/20 0.45
CA9 Q16790 1/20 0.45
MAOA P21397 3/20 0.44
MAOB P27338 3/20 0.44
MAPT P10636 2/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18094182 0.86 CA9 (0.57) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL29951659 0.84 AHR (0.56) PDE3BPDE3ACYP1A2CYP11B1CYP11B2
SCHEMBL14485082 0.84 AHR (0.56) PDE3BPDE3ACYP1A2CYP11B1CYP11B2
SCHEMBL426336 0.77 NPC1 (0.55) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL30114411 0.75 PKM (0.60) ALDH1A1PKM
SCHEMBL2586707 0.75 PKM (0.60) ALDH1A1PKM
SCHEMBL29954796 0.74 AHR (0.56) PDE3BPDE3ACRBNCA9SMYD3
SCHEMBL15415750 0.74 AHR (0.56) PDE3BPDE3ACRBNCA9SMYD3
SCHEMBL4170386 0.73 CYP11B1 (0.48) PDE3BPDE3ACYP11B1CYP11B2
SCHEMBL433753 0.73 PKM (0.58) NPC1MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176830-A1 Compounds, Compositions, and Methods ADAMS NICHOLAS D 2008-07-24 US disclosed
US-20080176830-A1 Compounds, Compositions, and Methods ADAMS NICHOLAS D 2008-07-24 US disclosed
US-20080176830-A1 Compounds, Compositions, and Methods ADAMS NICHOLAS D 2008-07-24 US disclosed
EP-1874753-A2 COMPOUNDS, COMPOSITIONS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2008-01-09 EP disclosed
WO-2006113432-A2 COMPOUNDS, COMPOSITIONS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2006-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176830-A1 Compounds, Compositions, and Methods ALPP, PCNA, MKI67 NPC1 366/4885MAPK13 2215/4885MAPK12 2653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.